|
132 |
Genematrix has launched two new product NeoPlex™ Monkeypox Virus Panels.
|
2022.07.29 |
|
131 |
Genematrix, New product NeoPlex™ HPV 29 detection kit is CE certified
|
2021.10.12 |
|
130 |
Genematrix, acquires COVID-19 vaccine substitute materials and secured superior neutralizing antibodies for commercial vaccines
|
2021.10.05 |
|
129 |
Genematrix, Acquires U.S. Patent for C-Tag™ Technology
|
2021.09.08 |
|
128 |
Genematrix, COVID-19 detection kits domestic authorization approved.
|
2021.08.30 |
|
127 |
Genematrix, "40-minutes-detection of COVID-19 FAST kit is now approved for MFDS in S.Korea"
|
2021.07.14 |
|
126 |
Genematrix acquires domestic manufacturing license for Flu/COVID19 detection kit
|
2021.07.05 |
|
125 |
Genematrix published paper on Zika virus vaccine efficiency in international academic journal
|
2021.06.14 |
|
124 |
Genematrix, acquires zica vaccine composition patent
|
2021.05.12 |
|
123 |
GeneMatrix applied for a patent of next-generation vaccine platform capable of rapid response.
|
2021.04.01 |
|
122 |
GeneMatrix, the leader of “K quarantine” shined in pandemic crisis.
|
2021.03.31 |
|
121 |
Genematrix has turned a profit - operating profit reached 2.2 billion Won last year
|
2021.02.15 |
|
120 |
Genematrix has proprietary technologies for molecular diagnostics with global competitiveness
|
2021.01.02 |
|
119 |
Genematrix, sales of 3.8 billion Won in the third quarter...235% ↑ compared to the previous year
|
2020.11.16 |
|
118 |
Genematrix acquired European CE certification for simultaneous detection kit : COVID-19 & Influenza
|
2020.10.29 |
ENG